Lakersrback Tuesday, 02/05/19 12:24:24 AM Re: None Post # of 45 Response to CTSO poster It's Toray of Japan that will be devastated Professor. The brilliant Sorb XL product will be Spectral's best friend. You see Toray manufactures the PMX column and has only given the rights to Spectral in exchange for the FDA stamp of approval. Spectral is in prime position to pounce and make a whack of bread off the sure to be blockbuster Sorb XL. Spectral already has the EAA, an FDA approved diagnostic to measure endotoxin and the state of the art and FDA approved CRRT machine to deliver the magical beads at bed side. Spectral's ingenuity will allow the XL filter to dominate the globe and instantly give it "theranostic" powers that will catapult the XL to the top of the sales charts. As you can see, I'm wildly excited about the Sorb XL and am anxiously awaiting it's first human usage so that Spectral can partner up with CTSO and make Endotoxemic Septic Shock a thing of the past. I just feel sorry for Toray and their 50,000 employees, sure they will continue on, but PMX might be absorbed by the spongy success of the Sorb XL. Fortunately Toray owns about 46 MILLION shares of Spectral, so they will at least benefit from the sales of the EAA and the CRRT machine that will help make the Sorb XL great and EDTXF shareholders a heck of a whack of money! Great post Professor, I like your advanced thinking! Remember too that there is talk of the Hemodefend being FDA'd in like 20 patients, wouldn't surprise me of the Sorb XL only required a similar amount! Dare to dream, look what jack grew from his magical beads!